AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 162 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334,347 | -59.5% | 13,509 | -53.6% | 0.00% | 0.0% |
| Q2 2023 | $825,244 | +32.6% | 29,140 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $622,532 | -8.6% | 27,102 | +11.8% | 0.00% | 0.0% |
| Q4 2022 | $680,968 | -0.0% | 24,251 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $681,000 | +26.6% | 24,086 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $538,000 | -42.3% | 24,276 | -24.3% | 0.00% | 0.0% |
| Q1 2022 | $933,000 | -17.2% | 32,068 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $1,127,000 | – | 34,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |